Found: 50
Select item for more details and to access through your institution.
The development of lurasidone for bipolar depression.
- Published in:
- Annals of the New York Academy of Sciences, 2015, v. 1358, n. 1, p. 95, doi. 10.1111/nyas.12965
- By:
- Publication type:
- Article
LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Remission in schizophrenia: 196-week, double-blind treatment with ziprasidone vs. haloperidol.
- Published in:
- International Journal of Neuropsychopharmacology, 2009, v. 12, n. 9, p. 1233, doi. 10.1017/S1461145709000352
- By:
- Publication type:
- Article
O12.5. EFFICACY AND SAFETY OF SEP-363856, A NOVEL PSYCHOTROPIC AGENT WITH A NON-D2 MECHANISM OF ACTION, IN THE TREATMENT OF SCHIZOPHRENIA: A 4-WEEK, RANDOMIZED, PLACEBO-CONTROLLED TRIAL.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, p. S199, doi. 10.1093/schbul/sbz021.269
- By:
- Publication type:
- Article
F106. EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAïVE ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 6-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, p. S293, doi. 10.1093/schbul/sbz018.518
- By:
- Publication type:
- Article
F26. C-REACTIVE PROTEIN AND RESPONSE TO LURASIDONE TREATMENT IN ADOLESCENTS WITH SCHIZOPHRENIA.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, p. S264, doi. 10.1093/schbul/sbz018.438
- By:
- Publication type:
- Article
Transformed PANSS Factors Intended to Reduce Pseudospecificity Among Symptom Domains and Enhance Understanding of Symptom Change in Antipsychotic-Treated Patients With Schizophrenia.
- Published in:
- Schizophrenia Bulletin, 2018, v. 44, n. 3, p. 593, doi. 10.1093/schbul/sbx101
- By:
- Publication type:
- Article
Prospective Study of Psychobiology in First-Episode Schizophrenia at Hillside Hospital.
- Published in:
- Schizophrenia Bulletin, 1992, v. 18, n. 3, p. 351, doi. 10.1093/schbul/18.3.351
- By:
- Publication type:
- Article
Dopaminergic Mechanisms in Idiopathic and Drug-Induced Psychoses.
- Published in:
- Schizophrenia Bulletin, 1990, v. 16, n. 1, p. 97, doi. 10.1093/schbul/16.1.97
- By:
- Publication type:
- Article
Ratings surveillance and reliability in a study of major depressive disorder with subthreshold hypomania (mixed features).
- Published in:
- International Journal of Methods in Psychiatric Research, 2018, v. 27, n. 4, p. N.PAG, doi. 10.1002/mpr.1729
- By:
- Publication type:
- Article
Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis.
- Published in:
- European Child & Adolescent Psychiatry, 2020, v. 29, n. 9, p. 1195, doi. 10.1007/s00787-019-01425-2
- By:
- Publication type:
- Article
A 6 Week Randomized Double-Blind Placebo-Controlled Trial of Ziprasidone for the Acute Depressive Mixed State.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0034757
- By:
- Publication type:
- Article
Effects of ulotaront on brain circuits of reward, working memory, and emotion processing in healthy volunteers with high or low schizotypy.
- Published in:
- Schizophrenia (2754-6993), 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41537-023-00385-6
- By:
- Publication type:
- Article
Ziprasidone for the Treatment of Acute Manic or Mixed Episodes Associated with Bipolar Disorder.
- Published in:
- CNS Drugs, 2007, v. 21, n. 10, p. 835, doi. 10.2165/00023210-200721100-00004
- By:
- Publication type:
- Article
Lurasidone for the Treatment of Irritability Associated with Autistic Disorder.
- Published in:
- Journal of Autism & Developmental Disorders, 2016, v. 46, n. 4, p. 1153, doi. 10.1007/s10803-015-2628-x
- By:
- Publication type:
- Article
Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis.
- Published in:
- BMC Psychiatry, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12888-021-03220-3
- By:
- Publication type:
- Article
Weight changes before and after lurasidone treatment: a real-world analysis using electronic health records.
- Published in:
- Annals of General Psychiatry, 2017, v. 16, p. 1, doi. 10.1186/s12991-017-0159-x
- By:
- Publication type:
- Article
Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis.
- Published in:
- Annals of General Psychiatry, 2017, v. 16, p. 1, doi. 10.1186/s12991-017-0133-7
- By:
- Publication type:
- Article
Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults.
- Published in:
- Neuropsychopharmacology, 2015, v. 40, n. 12, p. 2745, doi. 10.1038/npp.2015.124
- By:
- Publication type:
- Article
Long-Term Changes in Weight and Plasma Lipids during Maintenance Treatment with Ziprasidone.
- Published in:
- Neuropsychopharmacology, 2008, v. 33, n. 6, p. 985, doi. 10.1038/sj.npp.1301482
- By:
- Publication type:
- Article
Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study.
- Published in:
- Journal of Attention Disorders, 2020, v. 24, n. 2, p. 192, doi. 10.1177/1087054719864644
- By:
- Publication type:
- Article
Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment.
- Published in:
- International Journal of Bipolar Disorders, 2017, v. 5, n. 1, p. 1, doi. 10.1186/s40345-017-0075-7
- By:
- Publication type:
- Article
The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial.
- Published in:
- International Journal of Bipolar Disorders, 2016, v. 4, n. 1, p. 1, doi. 10.1186/s40345-016-0049-1
- By:
- Publication type:
- Article
Insight and Treatment Outcomes in Schizophrenia: Post-hoc Analysis of a Long-term, Double-blind Study Comparing Lurasidone and Quetiapine XR.
- Published in:
- Innovations in Clinical Neuroscience, 2017, v. 14, n. 11/12, p. 23
- By:
- Publication type:
- Article
Understanding Antipsychotic Drug Treatment Efects: A Novel Method to Reduce Pseudospeciicity of the Positive and Negative Syndrome Scale (PANSS) Factors.
- Published in:
- Innovations in Clinical Neuroscience, 2017, v. 14, n. 11/12, p. 54
- By:
- Publication type:
- Article
Data Quality Monitoring in Clinical Trials: Has It Been Worth It? An Evaluation and Prediction of the Future by All Stakeholders.
- Published in:
- Innovations in Clinical Neuroscience, 2016, v. 13, n. 1/2, p. 27
- By:
- Publication type:
- Article
Socioeconomic Disparities and Metabolic Risk in Veterans with Serious Mental Illness.
- Published in:
- Community Mental Health Journal, 2018, v. 54, n. 6, p. 725, doi. 10.1007/s10597-017-0215-7
- By:
- Publication type:
- Article
Treatment of early non-response in patients with schizophrenia: assessing the efficacy of antipsychotic dose escalation.
- Published in:
- BMC Psychiatry, 2015, v. 15, p. 1, doi. 10.1186/s12888-015-0629-0
- By:
- Publication type:
- Article
Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.
- Published in:
- BMC Psychiatry, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-244X-14-53
- By:
- Publication type:
- Article
Lurasidone: a novel antipsychotic agent for the treatment of schizophrenia and bipolar depression.
- Published in:
- BJPsych Bulletin, 2015, v. 39, n. 5, p. 237, doi. 10.1192/pb.bp.114.048793
- By:
- Publication type:
- Article
The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements.
- Published in:
- Psychopharmacology, 2006, v. 187, n. 3, p. 356, doi. 10.1007/s00213-006-0432-1
- By:
- Publication type:
- Article
Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pharmacokinetics and Exposure-Response Relationships of Dasotraline in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 2, p. 137, doi. 10.1007/s40261-015-0358-7
- By:
- Publication type:
- Article
Optimal Dosing of Lurasidone Studied in Acute Schizophrenia.
- Published in:
- MD Conference Express, 2015, v. 15, n. 11, p. 6, doi. 10.1177/1559897715593507
- By:
- Publication type:
- Article
Discovery of Nonracemic Amisulpride to Maximize Benefit/Risk of 5‐HT7 and D2 Receptor Antagonism for the Treatment of Mood Disorders.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 3, p. 808, doi. 10.1002/cpt.2282
- By:
- Publication type:
- Article
A Comparison of Ziprasidone and Risperidone in the Long-Term Treatment of Schizophrenia: A 44-Week, Double-Blind, Continuation Study.
- Published in:
- Canadian Journal of Psychiatry, 2009, v. 54, n. 1, p. 46, doi. 10.1177/070674370905400108
- By:
- Publication type:
- Article
Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia.
- Published in:
- BMC Psychiatry, 2016, v. 16, p. 1, doi. 10.1186/s12888-016-0879-5
- By:
- Publication type:
- Article
Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.
- Published in:
- BMC Psychiatry, 2016, v. 16, p. 1, doi. 10.1186/s12888-016-0865-y
- By:
- Publication type:
- Article
The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment.
- Published in:
- Bipolar Disorders, 2008, v. 10, n. 8, p. 900, doi. 10.1111/j.1399-5618.2008.00634.x
- By:
- Publication type:
- Article
Determination of dopamine D receptor occupancy by lurasidone using positron emission tomography in healthy male subjects.
- Published in:
- Psychopharmacology, 2013, v. 229, n. 2, p. 245, doi. 10.1007/s00213-013-3103-z
- By:
- Publication type:
- Article
Hospitalization outcomes in patients with schizophrenia after switching to lurasidone or quetiapine: a US claims database analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effect of food on the pharmacokinetics of lurasidone: results of two randomized, open-label, crossover studies.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2013, v. 28, n. 5, p. 495, doi. 10.1002/hup.2338
- By:
- Publication type:
- Article
Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US.
- Published in:
- ClinicoEconomics & Outcomes Research, 2013, v. 5, p. 459, doi. 10.2147/CEOR.S47990
- By:
- Publication type:
- Article
A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Ziprasidone in Black patients with schizophrenia: analysis of four short-term, double-blind studies.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Ziprasidone in Black Patients with Schizophrenia: Analysis of Four Short-term, Double-blind Studies.
- Published in:
- CNS Spectrums: The International Journal of Neuropsychiatric Medicine, 2009, v. 14, n. 9, p. 478, doi. 10.1017/S1092852900023543
- By:
- Publication type:
- Article
Long-term improvement in efficacy and safety after switching to ziprasidone in stable outpatients with schizophrenia.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Long-Term Improvement in Efficacy and Safety After Switching to Ziprasidone in Stable Outpatients with Schizophrenia.
- Published in:
- CNS Spectrums: The International Journal of Neuropsychiatric Medicine, 2008, v. 13, n. 10, p. 898, doi. 10.1017/S1092852900017004
- By:
- Publication type:
- Article
Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study.
- Published in:
- BMC Psychiatry, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12888-020-02523-1
- By:
- Publication type:
- Article